
It was another slow-ish week in ERISA-land, so we have no notable decision to highlight. However, read on to learn more about how (1) a wrongful death claim prompted by an astronomical increase in the price of an asthma inhaler is not preempted by ERISA (Schmidtknecht v. OptumRx Inc.), (2) pharmacy benefit managers have
